A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers-Reference-Cited by-同舟云学术

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers

Published:2018-11-28 Issue:6 Volume:111 Page:575-583
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Sabari Joshua K¹,Offin Michael¹,Stephens Dennis¹,Ni Andy¹,Lee Adrian²,Pavlakis Nick²,Clarke Stephen²,Diakos Connie I²,Datta Sutirtha¹,Tandon Nidhi¹,Martinez Andres¹,Myers Mackenzie L¹,Makhnin Alex¹,Leger Ysleni¹,Yu Helena A¹,Paik Paul K¹,Chaft Jamie E¹,Kris Mark G¹,Jeon Jeong O³,Borsu Laetitia A³,Ladanyi Marc³,Arcila Maria E³,Hernandez Jennifer⁴,Henderson Samantha⁴,Shaffer Tristan⁴,Garg Kavita⁴,DiPasquo Dan⁴,Raymond Christopher K⁴,Lim Lee P⁴,Li Mark⁴,Hellmann Matthew D¹,Drilon Alexander¹,Riely Gregory J¹,Rusch Valerie W⁵,Jones David R⁵,Rimner Andreas⁶,Rudin Charles M¹,Isbell James M⁵,Li Bob T¹

Affiliation:

1. Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY

2. Northern Cancer Institute, University of Sydney, Sydney, Australia

3. Diagnostic Molecular Pathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

4. Resolution Bioscience, Redmond, WA

5. Thoracic Service, Department of Surgery

6. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY

Funder

National Cancer Institute

National Institutes of Health

Nussbaum/Kuhn Foundation

Publisher

Oxford University Press (OUP)

Subject